Richard George is a vice president and advancement officer at Southern Virginia University. He previously served as co-founder and Chief Financial Officer of Clene Nanomedicine, a science-based company with proprietary technology integrating nanotechnology, advanced materials science, plasma physics, and biotechnology. Clene’s proprietary nanomedicine technology is a new form of matter for use in pharmaceuticals — ultrapure clean-surface nanocrystal suspensions in pharmaceutical grade water, with high therapeutic activity yet low toxicity to treat serious demyelinating diseases and cancer. Clene is nearing completion of Phase I – Clinical Trial for a rare demyelinating disease, and will follow with Clinical Trials in cancer. George was also Chief Executive Officer of General Resonance, LLC, the parent company of Clene.
George is a former partner and Chief Financial Officer of the Flagship Group, working in corporate strategy and innovation. He was part of the performance group of Sorenson Capital, a private equity firm. He has served in various financial and strategy positions with several large companies, including Hillenbrand Industries.
George graduated from Harvard Business School. As an undergraduate at Brigham Young University, he was a three time NCAA All American, member of the United States Olympic Team, U.S. Track and Field Team, National AAU champion, and winner of a bronze medal in the World Games. He also played football. He was inducted into the Utah Sports Hall of Fame, and the BYU Hall of Fame. He received a bachelor’s degree in Economics.
A member of The Church of Jesus Christ of Latter-day Saints, he has served in various positions, including bishop and stake presidency counselor.
He and his late wife, Jennifer Geer George, are the parents of six children.
B.A., Brigham Young University; M.B.A., Harvard Graduate School of Business
Southern Virginia University
One University Hill Drive
Buena Vista, VA 24416